LEXICON PHARMACEUTICALS, INC. (LXRX) › Net IncomeLEXICON PHARMACEUTICALS, INC. (LXRX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: -$82.78M2010: -$101.78M2011: -$116.22M2012: -$110.21M2013: -$104.13M2014: -$100.29M2015: -$4.68M2016: -$131.44M2017: -$122.99M2018: -$120.55M2019: $130.13M2020: -$58.57M2021: -$87.76M2022: -$101.94M2023: -$177.12M2024: -$200.40M2025: -$50.34M-$50.34M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$50.34M+74.9%2024-$200.40M-13.1%2023-$177.12M-73.7%2022-$101.94M-16.2%2021-$87.76M-49.8%2020-$58.57M-145.0%2019$130.13M+208.0%2018-$120.55M+2.0%2017-$122.99M+6.4%2016-$131.44M-2707.5%2015-$4.68M+95.3%2014-$100.29M+3.7%2013-$104.13M+5.5%2012-$110.21M+5.2%2011-$116.22M-14.2%2010-$101.78M-22.9%2009-$82.78M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share